Home > Journals > Minerva Chirurgica > Past Issues > Minerva Chirurgica 2017 December;72(6) > Minerva Chirurgica 2017 December;72(6):520-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   

Minerva Chirurgica 2017 December;72(6):520-9

DOI: 10.23736/S0026-4733.17.07437-5

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Colitis-associated colorectal cancer in patients with inflammatory bowel disease

Se-Jin BAEK, Seon-Hahn KIM

Department of Surgery, Korea University College of Medicine, Seoul, South Korea


PDF


Colitis-associated colorectal cancer (CACRC) is a major concern in patients with long-standing inflammatory bowel disease (IBD). CACRC can develop under the influence of several risk factors including longer duration and disease extent and shows clinical and molecular features different from those of sporadic CRC. Several academic societies have recommended surveillance guidelines for CACRC that develops in IBD patients. Patients are stratified according to risk for CRC and differentiated by surveillance colonoscopy and management. In the current article, we review CACRC in IBD patients generally and introduce future directions.


KEY WORDS: Inflammatory bowel diseases - Colitis, ulcerative - Crohn disease - Colorectal neoplasms - Colonoscopy

top of page